Zoetis Inc. filings document the animal health company's operating results, capital returns, financing activity and governance disclosures. Recent 8-K reports furnish quarterly and annual financial results, guidance, dividend declarations, investor presentations and other Regulation FD disclosures.
The company's proxy materials address board and compensation matters, including executive pay and equity-award disclosures. Other filings record its New York Stock Exchange-listed common stock and debt financing, including a private offering of convertible senior notes, related indenture terms and capped call transactions.
Stetter Mark reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Mark Stetter received a grant of 1,936 restricted stock units (RSUs) of Zoetis common stock. Each RSU represents the right to receive one Zoetis share and is issued at no cash cost, vesting after one year of continued service, subject to certain early-vesting events.
Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Roxanne Lagano reported equity awards on February 18, 2026. She received 3,664 restricted stock units and 14,499 stock options for Zoetis common stock, granted under the company’s equity and incentive plan.
Each RSU represents a right to one Zoetis share and is scheduled to vest in three equal installments on the first, second, and third anniversaries of the grant date, subject to continued service and certain earlier-vesting events. The stock options also vest in three equal annual installments and expire on the tenth anniversary of the grant date.
Zoetis Inc. director Antoinette Renee Leatherberry reported an equity award in the form of restricted stock units (RSUs). She acquired 1,936 RSUs at a stated price of $0.00 per unit, bringing this award to 1,936 RSUs. Each RSU represents a contingent right to receive one share of Zoetis common stock. According to the footnotes, these RSUs will vest and be settled in shares on the first anniversary of the grant date, February 18, 2026, subject to her continued service and certain earlier-vesting events. A separate line shows 1,619.3325 RSUs outstanding from a prior grant that is scheduled to vest and settle on February 19, 2025, under similar continued-service conditions.
Reed Willie M reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Willie M. Reed reported an equity award of 1,936 restricted stock units (RSUs) granted on February 18, 2026 at a price of $0.00 per unit. Each RSU represents a contingent right to receive one share of Zoetis common stock and was granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, including related dividend-equivalent units. According to the terms, these RSUs will vest and be settled in Zoetis common shares on the first anniversary of the grant date, February 18, 2026, subject to Reed’s continued service and certain earlier-vesting events.
Broadhurst Vanessa reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Vanessa Broadhurst received a grant of 1,936 restricted stock units (RSUs) on February 18, 2026 under the company’s equity and incentive plan. Each RSU represents a contingent right to one Zoetis common share and will vest on the first anniversary of the grant, subject to continued service and certain earlier-vesting events.
Hattersley Gavin reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Gavin Hattersley reported an equity award of 1,936 restricted stock units (RSUs) on February 18, 2026 at a stated price of $0.00 per unit, reflecting a grant under the company’s Amended and Restated 2013 Equity and Incentive Plan.
Each RSU represents a contingent right to receive one share of Zoetis common stock and will vest and be settled on the first anniversary of the grant date, February 18, 2026, subject to his continued service and certain earlier vesting conditions. Following these transactions, Hattersley directly holds RSUs including 1,619.3325 units from a prior grant scheduled to vest on February 19, 2025.
Driscoll Rimma reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Rimma Driscoll reported equity awards under the company’s Amended and Restated 2013 Equity and Incentive Plan. On February 18, 2026, she received 2,323 restricted stock units (RSUs) and 9,191 stock options, each RSU representing one share of common stock.
One-third of the new RSUs and one-third of the options vest on each of the first, second and third anniversaries of the grant date, subject to continued service and certain earlier‑vesting events. Each option allows her to buy Zoetis common stock and expires on the tenth anniversary of its grant.
PECK KRISTIN C reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. reported that Chief Executive Officer Kristin C. Peck received new equity awards. On February 18, 2026, she was granted 28,072 restricted stock units (RSUs) and 111,060 stock options at no cost, as compensation awards.
Each RSU represents a contingent right to one share of Zoetis common stock and, according to the plan terms, one-third of each RSU and one-third of each option will vest on the first, second, and third anniversaries of the February 18, 2026 grant date, subject to continued service and certain earlier vesting events. The options expire on the tenth anniversary of the grant date.
Ashton Nicholas reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Nicholas Ashton reported equity awards consisting of restricted stock units (RSUs) and stock options. On February 18, 2026, he received a grant of 4,148 RSUs and 16,413 stock options under the Zoetis Amended and Restated 2013 Equity and Incentive Plan.
Each RSU represents a contingent right to receive one share of Zoetis common stock. One-third of each RSU and one-third of each option vest on the first, second and third anniversaries of the grant date, subject to his continued service and certain earlier vesting events. Each option expires on the tenth anniversary of its grant date.
Zoetis Inc. Executive Vice President Jamie Brannan received new equity awards. On February 18, 2026, Brannan was granted 5,399 restricted stock units and 21,361 stock options, each at an exercise price of $0.00 per unit or option.
Each RSU represents a contingent right to receive one share of Zoetis common stock. One-third of the RSUs and one-third of the options will vest on each of the first, second and third anniversaries of the grant date, subject to continued service and certain earlier-vesting events. Following these grants, Brannan directly holds RSUs and multiple option positions reflecting prior annual awards under the company’s equity and incentive plans.